# Long-term supplementation of exogenous bile acids enhanced growth efficacy, hematology, non-specific immunity, and intestinal histomorphology, with significant liver dysfunction in Nile tilapia fingerlings

**Authors:** Elsayed A.A. Eldessouki, Gehad E. Elshopakey, Shaymaa Rezk, Mona Elsayed, Ahmed E.A. Mostafa, Samia Elbahnaswy

PMC · DOI: 10.1007/s11259-026-11129-z · 2026-03-23

## TL;DR

Adding bile acids to the diet of Nile tilapia fingerlings improved growth and immunity but caused liver damage over 16 weeks.

## Contribution

This study reveals the long-term effects of bile acid supplementation on both beneficial and harmful outcomes in Nile tilapia.

## Key findings

- Bile acid supplementation improved growth, digestion, and immunity in Nile tilapia.
- Supplementation increased intestinal health and altered gut microbiota composition.
- Prolonged use of bile acids caused significant liver dysfunction and oxidative stress.

## Abstract

A 16-week feeding trial was conducted to examine the effects of dietary exogenous bile acids (BAs) on growth performance, digestive enzyme activities, biochemical indices, antioxidant capacity, non-specific immune response, gene expression of proinflammatory cytokines, and liver and intestinal morphology in Nile tilapia (initial weight, 5.10 ± 0.22 g) reared in earthen ponds over an extended period. Two isonitrogenous (31.65% protein) and isolipidic (4.71%) experimental diets were formulated by adding a control diet (BA0) and 0.25 g bile acid per kg diet (BA0.25), respectively. The diets were randomly assigned to 6 hapas, each stocked with 20 fish and fed for 16 weeks. Supplementing with BA0.25 significantly enhanced growth metrics and intestinal digestive enzyme activities compared to BA0. Hematological analysis showed increased levels of white blood cells (WBC), lymphocytes, and neutrophils in the BA0.25 group compared to the control. Additionally, respiratory burst activity, phagocytic activity, and serum lysozyme activity were notably higher in fish fed BAs at 0.25 g kg− 1. Antioxidant parameters (SOD, CAT, GSH) were elevated, and the expression of the proinflammatory cytokine IL1β was downregulated in intestinal tissue from the BAs-supplemented group. Significant improvements in intestinal histomorphometry were observed in the BAs-supplemented group. BAs supplementation altered intestinal microbial composition, increasing total and Pseudomonas counts while reducing coliform levels. Interestingly, glucose, triglycerides, cholesterol, serum hepatic markers (ALT, AST, and ALP), hepatic oxidative MDA levels, and proinflammatory IL1β mRNA expression increased markedly in the supplemented-BAs group, while activity of antioxidant enzymes (SOD, CAT, GSH) and HSP70 mRNA expression were notably diminished. Moreover, significant alterations were shown in the hepatic tissue of the BAs-supplemented group. Consequently, dietary supplementation with bile acids for a prolonged period improves growth, intestinal health, and immunity; however, it harms the liver health of Nile tilapia.

The online version contains supplementary material available at 10.1007/s11259-026-11129-z.

## Linked entities

- **Genes:** IL1B (interleukin 1 beta) [NCBI Gene 3553], HSPA1A (heat shock protein family A (Hsp70) member 1A) [NCBI Gene 3303]
- **Chemicals:** GSH (PubChem CID 124886), ALT (PubChem CID 10219674), ALP (PubChem CID 1392), MDA (PubChem CID 1614)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, IL-1beta [NCBI Gene 100707066], beta actin [NCBI Gene 100534439], SOD [NCBI Gene 100693175], HSP70 [NCBI Gene 100701377], Heat shock protein 70 [NCBI Gene 100534448], CAT [NCBI Gene 100712286], cholecystokinin [NCBI Gene 100534492], SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, ALPP (alkaline phosphatase, placental) [NCBI Gene 250] {aka ALP, PALP, PLAP, PLAP-1}, FGFR4 [NCBI Gene 100692465], amylase [NCBI Gene 100534494]
- **Diseases:** intrahepatic cholestasis (MESH:D002780), hepatic damage (MESH:D056486), metabolic disorders (MESH:D008659), inflammation (MESH:D007249), cholestatic liver injury (MESH:D017093), metabolic disturbances (MESH:D024821), bile acid toxicity (MESH:C567652), cholestasis (MESH:D002779), bile infarcts (MESH:D007238), gallstones (MESH:D042882), Mitochondrial dysfunction (MESH:D028361), cytotoxic (MESH:D064420), hepatocellular toxicity (MESH:D006528), Neurotoxicity (MESH:D020258)
- **Chemicals:** H2O2 (MESH:D006861), H&amp;E (MESH:D006371), retinol palmitate (MESH:C014794), salt (MESH:D012492), GSH (MESH:D005978), alcian blue (MESH:D000423), pantothenic acid (MESH:D010205), BAs (MESH:D001647), Na2SeO3 (MESH:D018038), thiamine (MESH:D013831), TE (MESH:D013691), formalin (MESH:D005557), creatinine (MESH:D003404), paraffin (MESH:D010232), uric acid (MESH:D014527), folic acid (MESH:D005492), ROS (MESH:D017382), lithocholic acid (MESH:D008095), water (MESH:D014867), ZnCO3 (MESH:C036650), glucose (MESH:D005947), urea (MESH:D014508), NaCl (MESH:D012965), cyanocobalamine (MESH:D014805), choline (MESH:D002794), HCl (MESH:D006851), para-aminobenzoic acid (MESH:D010129), ammonia (MESH:D000641), nicotinic acid (MESH:D009525), Hematoxylin (MESH:D006416), carbohydrate (MESH:D002241), pendimethalin (MESH:C030856), oxygen (MESH:D010100), methomyl (MESH:D008724), ethanol (MESH:D000431), MDA (MESH:D008315), fatty acid (MESH:D005227), KCl (MESH:D011189), SYBR Green (MESH:C098022), copper sulphate (MESH:D019327), nitroblue tetrazolium (MESH:D009580), pyridoxine (MESH:D011736), cholecalciferol (MESH:D002762), TG (MESH:D013866), latex (MESH:D007840), AE63342FI-4800 (-), agarose (MESH:D012685), N, N-dimethylformamide (MESH:D004126), cholesterol (MESH:D002784), riboflavin (MESH:D012256), nitrates (MESH:D009566), EDTA (MESH:D004492), alpha-tocopherol acetate (MESH:D024502), Triglyceride (MESH:D014280), biotin (MESH:D001710), starch (MESH:D013213), menadione (MESH:D024483), fat (MESH:D005223), xylene (MESH:D014992), Lipid (MESH:D008055)
- **Species:** Schizothorax prenanti (species) [taxon 75362], Ctenopharyngodon idella (grass carp, species) [taxon 7959], Micrococcus luteus (species) [taxon 1270], Pangasianodon hypophthalmus (iridescent shark-catfish, species) [taxon 310915], Plectropomus leopardus (leopard coralgrouper, species) [taxon 160734], Actinopterygii (fishes, superclass) [taxon 7898], Chelon ramada (thinlip mullet, species) [taxon 30804], Mus musculus (house mouse, species) [taxon 10090], Cyprinus carpio (carp, species) [taxon 7962], Pseudomonas (RNA similarity group I, genus) [taxon 286], Tilapia (genus) [taxon 8126], Oreochromis niloticus (Nile tilapia, species) [taxon 8128], Acanthopagrus schlegelii (black porgy, species) [taxon 72011], Homo sapiens (human, species) [taxon 9606], Larimichthys crocea (croceine croaker, species) [taxon 215358], Micropterus salmoides (largemouth bass, species) [taxon 27706]

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13009007/full.md

---
Source: https://tomesphere.com/paper/PMC13009007